SUNNYVALE, Calif.--(BUSINESS WIRE)--Paracor Medical, Inc. announced today that it has received CE mark approval from its notified body, BSI, for the initial two products based upon its HeartNet™ technology platform. The approval will allow the expanded use of Paracor’s HeartNet and HeartNet-D products to treat patients suffering from systolic heart failure within the member countries of the European Union.
